The Valley Desk

NCT00093353 · Interventional trial

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Overall registry status Completed

Phase 1

Conditions Diarrhea, Drug/Agent Toxicity by Tissue/Organ, Neuroblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov